Clinical Trial Update: Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients [NA]

View source ↗

Summary

Clinical trial update showing a first-line gemcitabine regimen (GemCore+) for metastatic pancreatic adenocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Cancer Of Pancreas | NA | Status: RECRUITING